-
Innovation Ranking
NewInnovation Ranking – Ems-Chemie Holding AG
Ems-Chemie Holding AG (Ems-Chemie), a subsidiary of Emesta Holding AG, is a chemical company. It manufactures and markets polymers and specialty chemicals. The company’s products range includes bonding products, polyamides, damping systems, sealants, and coating products. Ems-Chemie also offers thermoplastic material, technical fibers, technical staple fiber, hot-melt adhesives, and epoxy-resins. It also provides reactive diluents, crosslinkers, fibers, ignitors, adhesion promoters, and granules. The company serves automotive, electro and electronic, industry and consumer goods, optic and packaging industries. It offers products...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – EM-5854 in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EM-5854 in Prostate Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EM-5854 in Prostate Cancer Drug Details: EM-5854 is under development for the...
-
Product Insights
Agere EM – ETAR do Este Waste Water Treatment Plant – Braga
The Agere EM – ETAR do Este Waste Water Treatment Plant – Braga project involves the construction of a wastewater treatment plant in Braga, northeast of Porto, Portugal. Equip yourself with the essential tools needed to make informed and profitable decisions with our Agere EM – ETAR do Este Waste Water Treatment Plant – Braga report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of...
-
Thematic Analysis
NewUkraine Conflict Impact – Thematic Intelligence
Ukraine Conflict Impact Report Overview The large-scale Russian invasion of Ukraine in February 2022 has dramatically restructured strategic priorities within the global defense sector either by developing innovative defense capabilities, or the re-invigorating previously stagnant market segments. As the geostrategic implications of this conflict continue to reverberate across global markets, the primary lesson learned is the need to upscale production capacity and leverage cost-efficiency across all domains of modern warfare, with investments driving innovation of both technology and operations throughout...
-
Company Insights
Innovation and Patenting activity of EM Systems Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of EM Systems Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Company Insights
Innovation and Patenting activity of Ems-Chemie Holding AG Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Ems-Chemie Holding AG Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – EM-113 in Autism Spectrum Disorder (ASD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EM-113 in Autism Spectrum Disorder (ASD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.EM-113 in Autism Spectrum Disorder (ASD)Drug Details:EM-113 is under development for...
-
Sector Analysis
NewEgypt Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2029
Egypt Defense Market Report Overview In 2024, Egypt's defense budget is worth $5.2 billion, inclusive of US military aid. The country’s defense budget will grow at a CAGR of more than 3% during 2025-2029. Egypt’s increasing military expenditure is reflected in an ongoing modernization effort to counter terrorism in the Sinai Peninsula, strained relations with Ethiopia, political turmoil following the democratic revolution, and maritime security concerns over the Suez Canal. Furthermore, the country’s strained relations with Ethiopia over the construction...
-
Sector Analysis
Portugal Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
Portugal Construction Market Report Overview The Portugal construction market size was $31.6 billion in 2023. The market will achieve an AAGR of more than 1% during 2025-2028. The growth is attributed to the increase in investments in transport and renewable energy infrastructure, with improvements in the electric vehicle market. Portugal Construction Market Outlook, 2023-2028 ($ Billion) Buy the Full Report to Know More about the Portugal Construction Market Forecast Download a Free Report Sample The Portugal construction market research report...
-
Product Insights
Androgenic Alopecia – Drugs In Development, 2023
Global Markets Direct’s, ‘Androgenic Alopecia - Drugs In Development, 2023’, provides an overview of the Androgenic Alopecia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Androgenic Alopecia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...